0001457612-18-000069.txt : 20180625 0001457612-18-000069.hdr.sgml : 20180625 20180625200758 ACCESSION NUMBER: 0001457612-18-000069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180621 FILED AS OF DATE: 20180625 DATE AS OF CHANGE: 20180625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BATE KENNETH CENTRAL INDEX KEY: 0001210238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36289 FILM NUMBER: 18918091 MAIL ADDRESS: STREET 1: C/O MILLENNIUM PHARMACEUTICALS INC STREET 2: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001457612 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510596811 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-876-8191 MAIL ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC DATE OF NAME CHANGE: 20090304 4 1 wf-form4_152997166026024.xml FORM 4 X0306 4 2018-06-21 0 0001457612 GENOCEA BIOSCIENCES, INC. GNCA 0001210238 BATE KENNETH C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140 1 0 0 0 Stock Option (Right to Buy) 0.99 2018-06-21 4 A 0 45000 0 A 2019-06-21 2028-06-21 Common Stock 45000.0 45000 D The option vests 100% on the first anniversary of the grant date. /s/ William Clark, Attorney-in-fact 2018-06-25